An Israeli academic has developed a virtual reality device to help people with neurodegenerative diseases to improve their walking. He is now seeking funding of about $500,000 to commercialise it and looking for manufacturing partner.
In a funk after years of stagnation and high unemployment, Germany is looking to an unlikely alliance between football and R&D to kick start the economy.
Acrongenomics Inc., a Swiss life science venture company and Molecular Vision Ltd., a spin-out from the Imperial College London, said they have signed a memorandum of understanding to jointly develop diagnostic devices for diabetes, drug abuse, STDs and cardiovascular diseases.
There is much more to a nation's "brain power" than how much it spends on R&D and education. The OECD tries to assess the broader picture by looking at "Investment in knowledge".
Napatech, a Danish company that specialised in raising the speed of Internet network appliances, said it has received $5 million from Ferd Venture, Northzone Ventures and existing shareholder DTU Innovation, a fund which is related to the Danish Technical University.
Who should benefit from the transfer of technology from the academic world into the business arena? The university that cooked up the ideas, or the company that turned them into money? How about society as a whole? An American Prof warns against micro managing the process.
Microsoft has stepped up its courtship of the international research community with the publication of an investigation of how computer science will underpin scientific discovery in the next 15 years.
Tectonic shifts in the patent landscape could follow on from high-profile lawsuits challenging what can be protected by a patent and how patents are enforced that are due to be heard by the US Supreme Court this month.
The competition to lure biotech investors and know-how is heating up in US states - and so are the legal battles between over fair and unfair incentives.
Six volunteers are in intensive care after a U.K. trial of an antibody treatment for leukaemia went horribly wrong, raising a raft of questions about drug testing.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.